Powered by the Scoliosis Research Society

SRS 30th International Meeting on Advanced Spine Techniques

SRS 30th International Meeting on Advanced Spine Techniques



Key Dates

January 23, 2023 Speaker Ready Room Opens 
January 23, 2023 Deadline to Make Changes to Title or Authors*
February 13, 2023 Deadline to Upload Manuscript
February 22, 2023 Deadline to upload Faculty presentations for CME review
March 17, 2023 Deadline to Upload E-Point Presentation
March 17, 2023 Online Speaker Ready Room Closes

*Authors may only be added to an abstract if they have an existing author account in the abstract submission system and a completed COI Disclosure Form. Changes may NOT be made to the body of the abstract, images, or tables. Sorry, no exceptions.


The presenting author (or one co-author) is required to register for the meeting and pay required registration fees. For information on registration, please visit Registration.


Location: Liffey Meeting Room 2

Presenters may upload their PowerPoint presentations in the Speaker Ready Room located in Liffey Meeting Room 2, Level 1 of the Convention Centre Dublin.


Wednesday, March 22   15:00 - 18:00
Thursday, March 23 08:00 - 18:00
Friday, March 24 08:00 - 16:30


Please upload presentations no later than 24 hours before the session is scheduled to begin.

Speaker Ready Room Now Open
Presentations should be in 16:9 format (widescreen). Here are instructions for converting from 4:3 to 16:9

AV and Presentation Upload

Presentations can be uploaded to the Speaker Ready Room. The Online Speaker Ready Room will close March 17, 2023 at 5:00 PM EDT (US).

Presentations should be in 16:9 format (widescreen). Here are instructions for converting from 4:3 to 16:9

Poster presentations should be up to 3 minutes long while Podium presentations are 4 minutes long.

Presenters who uploaded presentations to IMAST or last year's Annual Meeting Speaker Ready Room may use the same email account and password. If you have forgotten your password, click the 'Forgot Password' button and it will be sent to the email account you used. Presenters who did NOT upload in 2020, 2021 or 2022 should create a new account the first time logging into the site. The SRS members-only site password, abstract submission site password, and M&M site password will NOT work. If you need further technical assistance, please click the "SUPPORT" button at the top right of the Speaker Ready Room homepage.

Guidelines for E-Point Presentations


  • E-Point Presentations are limited to 13 slides.
    • 1st Slide – Must include title and authors of the abstract.
    • 2nd Slide – Must include all authors’ financial disclosures.
    • Last Slide – Should include references.


Presentations should be in 16:9 format (widescreen). For instructions on converting from 4:3 to 16:9, visit Powerpoint Conversion from 4:3 to16:9.

  • All E-Point Presentations must have audio narration (maximum 3 minutes)
  • No video, embedded video, sound, or transition animations may be included in your E-Point Presentation.
  • Presentations should be created using only Western English alpha-numeric characters.
  • Deadline to upload E-Point Presentations is 17 March, 2023 at 17:00 EST


E-Point Presentations will be displayed online.

E-Point Presentations Audio Narration Guidelines

For guidance on how to record the Audio Narration for your E-Point Presentation, please visit: Recording Narration Guide.

Questions:  If you have technical questions with your presentation upload, please contact John Charlebois at jc@integratedevents.com


Please note that all presentations and e-posters must include a slide listing all of the author(s)' financial disclosures with commercial interests.

Product Name Use Policy

SRS strongly prefers that pharmaceuticals and proprietary software/databases as well as surgical approaches or specific instrumentation such as “Surgimap, MIMICS, EOS Imaging, ROTEM, Isola, TSRH, CD, XLIF, DLIF, AxiaLIF, Solera, Vertex, Expedium, Mountaineer, Shilla, VEPTR etc.,” are not used in presentations. These terms should be replaced by a generic term or description of the drug, software/database and/or instrumentation or technique unless the use of the term directly impacts learners’ understanding of the presentation or data. Instrumentation may also be referred to when the device name is a landmark system that is no longer sold (i.e. Harrington, Cotrel-Dubousset, Luque).

Company names and logos may not be used in any presentation (including in images) at IMAST.

It is recognized that studies evaluating a device or devices or comparing different devices or techniques may require the use of product or technique names. If a device trade name or industry developed technique using a trademarked name are used in an abstract or presentation, it will be specifically reviewed by the CME Committee for evaluation of any potential conflict of interest. When there is a known potential conflict of interest, an expanded verbal disclosure will be necessary at the time of presentation. Furthermore, if a product name is mentioned, the audience should be informed of why it is necessary to give the name.

Please notify us at cme@srs.org if you plan to use a product name in your presentation.

Non-Exclusive License and Attestation

Podium & E-Poster Presenters

A Non-Exclusive License and Attestation Form must be completed in the Speaker Management System. Podium and e-poster presenters will be prompted to complete this form upon logging in to accept their presentation(s).


Both a Non-Exclusive License Form and Attestation Form must be completed in the Speaker Management System.  Faculty will be prompted to complete these forms upon logging in to accept their presentation(s).

Final Program

Abstracts will be published in the final program as originally submitted. Any corrections to the title or author listing are no longer being accepted. SRS cannot make edits or additions to the abstract text.

CME Accreditation Policies

IMAST will be CME accredited, and it is therefore essential that the presentations and e-posters are free from commercial influence. References to particular commercial products must use their generic name or be balanced by referring to other similar products.